Satori-01

N/A

Report date: 2023/07/28 15:02:02

Base Information

Drug NameSatori-01
Drug Alias NamePrimary human muscle stem cellsSatori-01
ClassificationCell and gene therapy > Cell therapy > Source of cells > Muscle-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Muscle stem cell therapyCell and gene therapy > Cell therapy > Donor > Autologous
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsUrinary IncontinenceEpispadias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCharite University, Berlin, GermanyMyoPax
China Registration ClassN/A

Develop Information

Active CompaniesCharite University, Berlin, Germany
Inactive CompaniesN/A
Active IndicationsUrinary IncontinenceEpispadias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A